CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,827,352 | +331.7% | 1,340,300 | +395.3% | 0.03% | +285.7% |
| Q3 2022 | $1,813,000 | -84.0% | 270,600 | -69.7% | 0.01% | -87.3% |
| Q4 2020 | $11,297,000 | +48.4% | 893,741 | +15.3% | 0.06% | +41.0% |
| Q3 2020 | $7,611,000 | +315.4% | 775,000 | +320.9% | 0.04% | +225.0% |
| Q2 2020 | $1,832,000 | +117.3% | 184,138 | +222.3% | 0.01% | +200.0% |
| Q3 2017 | $843,000 | -79.9% | 57,134 | -86.2% | 0.00% | -86.2% |
| Q3 2016 | $4,190,000 | -7.7% | 414,479 | +2.5% | 0.03% | -6.5% |
| Q2 2016 | $4,542,000 | -5.1% | 404,479 | +15.4% | 0.03% | -16.2% |
| Q1 2016 | $4,786,000 | -42.1% | 350,372 | -36.9% | 0.04% | -35.1% |
| Q2 2015 | $8,264,000 | +3.9% | 555,000 | +5.7% | 0.06% | +5.6% |
| Q1 2015 | $7,954,000 | +19.4% | 525,200 | +5.0% | 0.05% | +14.9% |
| Q4 2014 | $6,660,000 | -1.1% | 500,000 | -6.4% | 0.05% | -7.8% |
| Q3 2014 | $6,736,000 | – | 534,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |